Pnc Financial Services Group, Inc. Neogenomics Inc Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 15,610 shares of NEO stock, worth $210,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,610
Previous 14,840
5.19%
Holding current value
$210,578
Previous $218,000
17.89%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NEO
# of Institutions
296Shares Held
125MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$265 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$189 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$92.9 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$89.1 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$88.2 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.7B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...